ArticleBMC medicine2022

Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy.

Yibin Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.